Breztri vs Wixela
What to choose Breztri or Wixela
Breztri and Wixela are inhalers both of Control type. Breztri and Wixela are both brand inhalers. Breztri is manufactured by pharmaceutical company AstraZeneca, while Wixela is manufactured by Viatris. The main substances of Breztri are Budesonide and Formoterol. The available dosages for Breztri are 160 mcg / 4,8 mcg. The main substances of Wixela are Fluticasone and Salmeterol. The available dosage for Wixela is 250/50.
The current cost for Breztri is approximately $556.34 while average cost for Wixela is approximately $240, said Valentin Myers, an Assistant Professor at the University of Alaska-Fairbanks and a Medical Director at a clinic that uses Breztri and Wixela.
Breztri and Wixela Comparison
| Breztri | Wixela | |
|---|---|---|
| Type: | Control | Control |
| Manufacturer: | AstraZeneca | Viatris |
| Substance: | Budesonide + Formoterol | Fluticasone + Salmeterol |
| Dosage: | 160 mcg / 4,8 mcg | 250/50 |
| Avg Price: | $556.34 | $240 |